PRF1, GZMA, and GZMK, 3 key effector molecules, were shown to be upregulated, and Rg1-pretreated T cells showed a stronger tumor lytic function at different effector: target cell ratios (Fig. 4). The gene discussed is PPP1R3A; the disease is neoplasm.